PMID: 9169090Apr 1, 1997Paper

Decreased C-MYC and BCL2 expression correlates with methylprednisolone-mediated inhibition of Raji lymphoma growth

Biochemical and Molecular Medicine
G MorrisP H Gumerlock

Abstract

Methylprednisolone (MP) and related corticosteroids are a fundamental part of regimens used to treat lymphoma and leukemia. In many of these malignancies, oncogenic activation of C-MYC and BCL2 is seen. Abnormalities of the tumor suppressor p53, which exerts growth-suppressing and apoptosis-enhancing functions through the transcriptional regulation of downstream genes including CDKN1, GADD45, and BCL2, are also often found. The goal was to determine the modulation of expression of the oncogenes (C-MYC and BCL2), the p53 pathway described above, and the apoptosis marker TGF-beta 1 in the human Raji lymphoma following MP treatment. Raji xenografts were grown in nude mice and growth curves characterized by sequential measurement. Mice were treated daily for 8 days with MP. Tumors were harvested untreated, or at 1 or 8 days after cessation of MP treatment, and the RNA was extracted. RT-PCR was used to determine the level of mRNA expression of the genes. Tumor growth was greatly reduced in the MP-treated mice. Gene expression levels for C-MYC and BCL2 were reduced at 1 day following MP and approached control levels 8 days after MP treatment. Expression levels of p53, CDKN1, and GADD45 were moderately and coordinately decreased at 1 ...Continue Reading

References

Jun 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H M VriesendorpS E Order
Jun 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·G GaidanoR Dalla-Favera
Feb 1, 1990·Leukemia·A Butturini, R P Gale
May 1, 1988·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·P H GumerlockF J Meyers
Mar 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·Y Tsujimoto
Jan 1, 1986·Annual Review of Genetics·M D Cole
Jan 1, 1986·Annual Review of Immunology·K Kelly, U Siebenlist
Jun 21, 1985·Science·Y TsujimotoC M Croce
Dec 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·R TaubP Leder
Jun 15, 1994·Journal of the National Cancer Institute·S G ChiP H Gumerlock
Jul 1, 1994·The Journal of Urology·J R FishmanR W deVere White
Apr 1, 1995·Hybridoma·J P LewisS J Denardo
Aug 12, 1993·The New England Journal of Medicine·M S KaminskiG M Butchko
Sep 30, 1994·Science·H Hermeking, D Eick
Jan 1, 1994·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T A Waldmann
Nov 19, 1993·Cell·W S el-DeiryB Vogelstein
Dec 16, 1993·Nature·Y XiongD Beach
Jul 1, 1993·Molecular and Cellular Biology·Q ZhanA J Fornace
Mar 1, 1993·British Journal of Cancer·W BurschR Schulte-Hermann
Jan 1, 1996·CA: a Cancer Journal for Clinicians·S L ParkerP A Wingo
Nov 1, 1961·Proceedings of the Society for Experimental Biology and Medicine·R SCHREK
Feb 1, 1964·Lancet·J V PULVERTAFT

❮ Previous
Next ❯

Citations

Oct 9, 2001·Cell Biology International·Y Zhang, L Nie
Jun 14, 2000·Cancer Biotherapy & Radiopharmaceuticals·R T O'DonnellG L DeNardo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology
S J DeNardoA L Epstein
© 2021 Meta ULC. All rights reserved